# Accel Entertainment, Inc.: financial statements, quarterly

ACEL · NYSE · CIK 1698991 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acel.md) · [Financials](/companies/acel/financials.md) · [Filings](/companies/acel/filings.md) · [Insiders](/companies/acel/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acel/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [287](/filings/0001698991-24-000042.md) | [297 d](/filings/0001698991-26-000018.md) | [302](/filings/0001698991-25-000023.md) | [309](/filings/0001698991-25-000034.md) | [302](/filings/0001698991-25-000051.md) | [318 d](/filings/0001698991-26-000018.md) | [324](/filings/0001698991-26-000037.md) | [336](/filings/0001698991-26-000059.md) | [330](/filings/0001698991-25-000051.md) | [341 d](/filings/0001698991-26-000018.md) | [352](/filings/0001698991-26-000037.md) | [368](/filings/0001698991-26-000059.md) |
| Operating income | $m | [25.1](/filings/0001698991-24-000042.md) | [25.5 d](/filings/0001698991-26-000018.md) | [25.6](/filings/0001698991-25-000023.md) | [22.7](/filings/0001698991-25-000034.md) | [21.8](/filings/0001698991-25-000051.md) | [20.8 d](/filings/0001698991-26-000018.md) | [26.0](/filings/0001698991-26-000037.md) | [26.9](/filings/0001698991-26-000059.md) | [25.4](/filings/0001698991-25-000051.md) | [29.7 d](/filings/0001698991-26-000018.md) | [27.1](/filings/0001698991-26-000037.md) | [32.1](/filings/0001698991-26-000059.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.6](/filings/0001698991-24-000042.md) | [3.4 d](/filings/0001698991-26-000018.md) | [4.8](/filings/0001698991-25-000023.md) | [3.9](/filings/0001698991-25-000034.md) | [3.6](/filings/0001698991-25-000051.md) | [6.2 d](/filings/0001698991-26-000018.md) | [5.0](/filings/0001698991-26-000037.md) | [5.1](/filings/0001698991-26-000059.md) | [4.5](/filings/0001698991-25-000051.md) | [6.1 d](/filings/0001698991-26-000018.md) | [5.4](/filings/0001698991-26-000037.md) | [5.9](/filings/0001698991-26-000059.md) |
| Net income | $m | [10.5](/filings/0001698991-24-000042.md) | [16.0 d](/filings/0001698991-26-000018.md) | [7.4](/filings/0001698991-25-000051.md) | [14.6](/filings/0001698991-25-000051.md) | [4.9](/filings/0001698991-25-000051.md) | [8.4 d](/filings/0001698991-26-000018.md) | [14.6](/filings/0001698991-26-000059.md) | [7.3](/filings/0001698991-26-000059.md) | [13.4](/filings/0001698991-25-000051.md) | [16.2 d](/filings/0001698991-26-000018.md) | [14.7](/filings/0001698991-26-000059.md) | [12.5](/filings/0001698991-26-000059.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001698991-24-000042.md) | not reported | [0.09](/filings/0001698991-25-000023.md) | [0.17](/filings/0001698991-25-000034.md) | [0.06](/filings/0001698991-25-000051.md) | not reported | [0.17](/filings/0001698991-26-000037.md) | [0.08](/filings/0001698991-26-000059.md) | [0.16](/filings/0001698991-25-000051.md) | not reported | [0.17](/filings/0001698991-26-000037.md) | [0.15](/filings/0001698991-26-000059.md) |
| Basic EPS | $ per share | [0.12](/filings/0001698991-24-000042.md) | not reported | [0.09](/filings/0001698991-25-000023.md) | [0.17](/filings/0001698991-25-000034.md) | [0.06](/filings/0001698991-25-000051.md) | not reported | [0.17](/filings/0001698991-26-000037.md) | [0.09](/filings/0001698991-26-000059.md) | [0.16](/filings/0001698991-25-000051.md) | not reported | [0.18](/filings/0001698991-26-000037.md) | [0.15](/filings/0001698991-26-000059.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [230](/filings/0001698991-23-000049.md) | [262](/filings/0001698991-25-000011.md) | [254](/filings/0001698991-24-000025.md) | [255](/filings/0001698991-24-000037.md) | [265](/filings/0001698991-24-000042.md) | [281](/filings/0001698991-26-000018.md) | [272](/filings/0001698991-25-000023.md) | [265](/filings/0001698991-25-000034.md) | [290](/filings/0001698991-25-000051.md) | [297](/filings/0001698991-26-000059.md) | [274](/filings/0001698991-26-000037.md) | [255](/filings/0001698991-26-000059.md) |
| Current assets | $m | [283](/filings/0001698991-23-000049.md) | [313](/filings/0001698991-25-000011.md) | [309](/filings/0001698991-24-000025.md) | [322](/filings/0001698991-24-000037.md) | [323](/filings/0001698991-24-000042.md) | [326](/filings/0001698991-26-000018.md) | [316](/filings/0001698991-25-000023.md) | [310](/filings/0001698991-25-000034.md) | [334](/filings/0001698991-25-000051.md) | [343](/filings/0001698991-26-000059.md) | [317](/filings/0001698991-26-000037.md) | [324](/filings/0001698991-26-000059.md) |
| Total assets | $m | [871](/filings/0001698991-23-000049.md) | [913](/filings/0001698991-25-000011.md) | [919](/filings/0001698991-24-000025.md) | [950](/filings/0001698991-24-000037.md) | [950](/filings/0001698991-24-000042.md) | [1,048](/filings/0001698991-26-000018.md) | [1,047](/filings/0001698991-25-000023.md) | [1,056](/filings/0001698991-25-000034.md) | [1,085](/filings/0001698991-25-000051.md) | [1,103](/filings/0001698991-26-000059.md) | [1,071](/filings/0001698991-26-000037.md) | [1,097](/filings/0001698991-26-000059.md) |
| Current liabilities | $m | [92.2](/filings/0001698991-23-000049.md) | [110](/filings/0001698991-25-000011.md) | [109](/filings/0001698991-24-000025.md) | [106](/filings/0001698991-24-000037.md) | [119](/filings/0001698991-24-000042.md) | [118](/filings/0001698991-26-000018.md) | [131](/filings/0001698991-25-000023.md) | [117](/filings/0001698991-25-000034.md) | [130](/filings/0001698991-25-000051.md) | [131](/filings/0001698991-26-000059.md) | [117](/filings/0001698991-26-000037.md) | [131](/filings/0001698991-26-000059.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [830](/filings/0001698991-26-000059.md) | [795](/filings/0001698991-26-000037.md) | [809](/filings/0001698991-26-000059.md) |
| Long-term debt | $m | [484](/filings/0001698991-23-000049.md) | [514](/filings/0001698991-25-000011.md) | [511](/filings/0001698991-24-000025.md) | [537](/filings/0001698991-24-000037.md) | [526](/filings/0001698991-24-000042.md) | [561](/filings/0001698991-26-000018.md) | [546](/filings/0001698991-25-000023.md) | [561](/filings/0001698991-25-000034.md) | [565](/filings/0001698991-25-000051.md) | [570](/filings/0001698991-26-000059.md) | [551](/filings/0001698991-26-000037.md) | [543](/filings/0001698991-26-000059.md) |
| Current portion of debt | $m | [28.5](/filings/0001698991-23-000049.md) | [28.5](/filings/0001698991-25-000011.md) | [28.5](/filings/0001698991-24-000025.md) | [28.5](/filings/0001698991-24-000037.md) | [28.5](/filings/0001698991-24-000042.md) | [34.4](/filings/0001698991-26-000018.md) | [34.3](/filings/0001698991-25-000023.md) | [34.0](/filings/0001698991-25-000034.md) | [30.3](/filings/0001698991-25-000051.md) | [37.6](/filings/0001698991-26-000059.md) | [30.0](/filings/0001698991-26-000037.md) | [30.0](/filings/0001698991-26-000059.md) |
| Shareholders' equity | $m | [199](/filings/0001698991-24-000042.md) | [198](/filings/0001698991-26-000018.md) | [202](/filings/0001698991-25-000051.md) | [209](/filings/0001698991-25-000051.md) | [207](/filings/0001698991-25-000051.md) | [255](/filings/0001698991-26-000059.md) | [259](/filings/0001698991-26-000059.md) | [261](/filings/0001698991-26-000059.md) | [267](/filings/0001698991-25-000051.md) | [270](/filings/0001698991-26-000059.md) | [272](/filings/0001698991-26-000059.md) | [284](/filings/0001698991-26-000059.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.2 d](/filings/0001698991-24-000042.md) | [40.5 d](/filings/0001698991-26-000018.md) | [28.8](/filings/0001698991-25-000023.md) | [28.9 d](/filings/0001698991-25-000034.md) | [50.1 d](/filings/0001698991-25-000051.md) | [13.5 d](/filings/0001698991-26-000018.md) | [44.8](/filings/0001698991-26-000037.md) | [19.8 d](/filings/0001698991-26-000059.md) | [55.2 d](/filings/0001698991-25-000051.md) | [31.1 d](/filings/0001698991-26-000018.md) | [42.7](/filings/0001698991-26-000037.md) | [20.0 d](/filings/0001698991-26-000059.md) |
| Capital expenditure | $m | [18.6 d](/filings/0001698991-24-000042.md) | [21.5 d](/filings/0001698991-26-000018.md) | [20.6](/filings/0001698991-25-000023.md) | [17.5 d](/filings/0001698991-25-000034.md) | [16.9 d](/filings/0001698991-25-000051.md) | [11.5 d](/filings/0001698991-26-000018.md) | [26.8](/filings/0001698991-26-000037.md) | [26.0 d](/filings/0001698991-26-000059.md) | [21.0 d](/filings/0001698991-25-000051.md) | [15.1 d](/filings/0001698991-26-000018.md) | [22.9](/filings/0001698991-26-000037.md) | [11.1 d](/filings/0001698991-26-000059.md) |
| Share repurchases | $m | [3.3 d](/filings/0001698991-24-000042.md) | [14.4 d](/filings/0001698991-26-000018.md) | [6.1](/filings/0001698991-25-000023.md) | [9.2 d](/filings/0001698991-25-000034.md) | [6.2 d](/filings/0001698991-25-000051.md) | [4.0 d](/filings/0001698991-26-000018.md) | [10.2](/filings/0001698991-26-000037.md) | [6.7 d](/filings/0001698991-26-000059.md) | [6.8 d](/filings/0001698991-25-000051.md) | [16.2 d](/filings/0001698991-26-000018.md) | [12.1](/filings/0001698991-26-000037.md) | [5.6 d](/filings/0001698991-26-000059.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [90.5](/filings/0001698991-23-000049.md) | [87.1](/filings/0001698991-24-000025.md) | [86.8](/filings/0001698991-24-000037.md) | [87.1](/filings/0001698991-24-000042.md) | [85.3](/filings/0001698991-25-000023.md) | [85.1](/filings/0001698991-25-000034.md) | [84.3](/filings/0001698991-25-000051.md) | [87.2](/filings/0001698991-26-000037.md) | [86.9](/filings/0001698991-26-000059.md) | [86.1](/filings/0001698991-25-000051.md) | [84.1](/filings/0001698991-26-000037.md) | [83.4](/filings/0001698991-26-000059.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 81,193,475 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001698991-26-000059.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.